Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 4
2022 7
2023 6
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
MR-guided radiotherapy of moving targets.
Spindeldreier CK, Klüter S, Hoegen P, Buchele C, Rippke C, Tonndorf-Martini E, Debus J, Hörner-Rieber J. Spindeldreier CK, et al. Among authors: rippke c. Radiologe. 2021 Dec;61(Suppl 1):39-48. doi: 10.1007/s00117-020-00781-4. Epub 2021 Jan 4. Radiologe. 2021. PMID: 33392627 English.
Dosimetric Benefit of Adaptive Magnetic Resonance-Guided Stereotactic Body Radiotherapy of Liver Metastases.
Weykamp F, Katsigiannopulos E, Piskorski L, Regnery S, Hoegen P, Ristau J, Renkamp CK, Liermann J, Forster T, Lang K, König L, Rippke C, Buchele C, Debus J, Klüter S, Hörner-Rieber J. Weykamp F, et al. Among authors: rippke c. Cancers (Basel). 2022 Dec 8;14(24):6041. doi: 10.3390/cancers14246041. Cancers (Basel). 2022. PMID: 36551527 Free PMC article.
Long-Term Clinical Results of MR-Guided Stereotactic Body Radiotherapy of Liver Metastases.
Weykamp F, Hoegen P, Regnery S, Katsigiannopulos E, Renkamp CK, Lang K, König L, Sandrini E, Meixner E, Rippke C, Buchele C, Liermann J, Debus J, Klüter S, Hörner-Rieber J. Weykamp F, et al. Among authors: rippke c. Cancers (Basel). 2023 May 17;15(10):2786. doi: 10.3390/cancers15102786. Cancers (Basel). 2023. PMID: 37345123 Free PMC article.
Stereotactic body radiotherapy of lymph node metastases under MR-guidance: First clinical results and patient-reported outcomes.
Weykamp F, Herder-Wagner C, Regnery S, Hoegen P, Renkamp CK, Liermann J, Rippke C, Koerber SA, König L, Buchele C, Klüter S, Debus J, Hörner-Rieber J. Weykamp F, et al. Among authors: rippke c. Strahlenther Onkol. 2022 Jan;198(1):56-65. doi: 10.1007/s00066-021-01834-w. Epub 2021 Sep 1. Strahlenther Onkol. 2022. PMID: 34468783 Free PMC article.
Adaptive MR-Guided Stereotactic Radiotherapy is Beneficial for Ablative Treatment of Lung Tumors in High-Risk Locations.
Regnery S, Buchele C, Weykamp F, Pohl M, Hoegen P, Eichkorn T, Held T, Ristau J, Rippke C, König L, Thomas M, Winter H, Adeberg S, Debus J, Klüter S, Hörner-Rieber J. Regnery S, et al. Among authors: rippke c. Front Oncol. 2022 Jan 11;11:757031. doi: 10.3389/fonc.2021.757031. eCollection 2021. Front Oncol. 2022. PMID: 35087746 Free PMC article.
Comparison of different dose accumulation strategies to estimate organ doses after stereotactic magnetic resonance-guided adaptive radiotherapy.
Regnery S, Leiner L, Buchele C, Hoegen P, Sandrini E, Held T, Deng M, Eichkorn T, Rippke C, Renkamp CK, König L, Lang K, Adeberg S, Debus J, Klüter S, Hörner-Rieber J. Regnery S, et al. Among authors: rippke c. Radiat Oncol. 2023 May 29;18(1):92. doi: 10.1186/s13014-023-02284-7. Radiat Oncol. 2023. PMID: 37248504 Free PMC article.
To fly or not to fly: Stereotactic MR-guided adaptive radiotherapy effectively treats ultracentral lung tumors with favorable long-term outcomes.
Regnery S, Katsigiannopulos E, Hoegen P, Weykamp F, Sandrini E, Held T, Deng M, Eichkorn T, Buchele C, Rippke C, Renkamp CK, König L, Lang K, Thomas M, Winter H, Adeberg S, Klüter S, Debus J, Hörner-Rieber J. Regnery S, et al. Among authors: rippke c. Lung Cancer. 2023 May;179:107175. doi: 10.1016/j.lungcan.2023.03.011. Epub 2023 Mar 21. Lung Cancer. 2023. PMID: 36965207
16 results